Infection Risk, Mortality, and Hypogammaglobulinemia Prevalence and Associated Factors in Adults Treated with Rituximab: A Tertiary Care Center Experience

Background: Rituximab is a human monoclonal antibody directed against the B-cell transmembrane protein CD20. Although well-tolerated, given its mechanism of action, rituximab can induce a state of severe immunosuppression, increasing the risk of opportunistic and fulminant infection and mortality. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhamadh, Moustafa S., Alhowaish, Thamer S., Mathkour, Alaa, Altamimi, Bayan, Alheijani, Shahd, Alrashid, Abdulrahman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660466/
https://www.ncbi.nlm.nih.gov/pubmed/37987416
http://dx.doi.org/10.3390/clinpract13060115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660466/
https://www.ncbi.nlm.nih.gov/pubmed/37987416
http://dx.doi.org/10.3390/clinpract13060115

Ejemplares similares